VANCOUVER, British Columbia--(BUSINESS WIRE)--HYAS Infosec, the adversary infrastructure platform provider that offers unparalleled visibility, protection, and security against all kinds of malware and attacks, today announced that it has been selected as winner of the “Best Overall Healthcare Cybersecurity” award in the 8th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.
HYAS gives security teams the intelligence and tools to identify, track, and attribute attacks with unprecedented speed and efficiency. HYAS Insight threat intelligence and HYAS Protect protective DNS provide proactive intelligence that enables organizations to defend against breaches and attacks, recognize attacks as they happen, and thwart them before damage can occur.
HYAS Insight provides unprecedented visibility and proactive intelligence about attacks focusing on Verdicts, Related Infrastructure, and Attribution or “VRA,” allowing investigators and researchers to understand the nature of the threats they are facing, and what their adversaries are likely to do in the future, even providing real-time alerts when criminals create new infrastructure. Utilized daily by Fortune 500 companies around the world, HYAS Insight provides invaluable insights for both threat and fraud teams, allowing them to close cases faster and deliver the key intelligence that the business requires.
HYAS Protect immediately identifies attempted communication to malicious domains and infrastructure external to an organization. As part of a zero-trust architecture, it enables cyber resiliency by detecting, interrupting and blocking low-and-slow attacks, supply chain attacks, phishing, and other intrusions that infiltrate and hide in organizational networks. HYAS Protect provides the critical visibility and protection required to help augment security teams and SOCs, reducing alert fatigue and improving network intelligence.
HYAS’ Adversary Infrastructure Platform, with its unique underlying graph database that ingests various authoritative data, is a distinctive solution that connects one dataset to another, using proprietary algorithms to build and update connections in the graph database and providing the foundation for “VRA” – Verdicts, Related Infrastructure, and Attribution. The technology goes beyond surface-level analysis, employing AI to establish relationships between datasets, and uncovering hidden attack infrastructures, to provide the answers, insights, and intelligence that others cannot.
“Thank you to MedTech Breakthrough for recognizing that the medical and health technology industry, long a prime and favorite target for cyberattacks, now has an effective new weapon and partner with HYAS,” said David Ratner, CEO, HYAS Infosec. “Our solutions were designed to put the control back into the security and IT teams of the medical and health technology industry - where it belongs. We’ll continue to devise tools that play a pivotal role in preventing and thwarting cybercrime within healthcare organizations and empowering them with proactive threat intelligence and defense.”
The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data & Privacy, and many more. This year’s program attracted thousands of nominations from over 18 different countries throughout the world.
“HYAS gives healthcare organizations a significant strategic advantage, helping them identify and stop cyberattacks. In an era where cyber threats evolve and adapt, these organizations face ongoing threats where they are reactive and get caught flat-footed, trying to mount a defense, and scrambling to mitigate damage,” said Steve Johansson, managing director, MedTech Breakthrough. “The HYAS Insight threat intelligence and investigation platform and HYAS Protect protective DNS flip the cybersecurity and defense game on its head. No longer do healthcare organizations have to scramble to contain or mitigate yet another cyberattack while hemorrhaging valuable data and assets.”
About HYAS
HYAS is the world-leading authority on cyber adversary infrastructure and communication to that infrastructure. HYAS is dedicated to protecting organizations and solving intelligence problems through detection of adversary infrastructure and anomalous communication patterns.
We help businesses see more, do more, and understand more in real time about the nature of the threats they face. HYAS turns metadata into actionable threat intelligence, actual adversary visibility, and protective DNS that renders malware inoperable. For more information visit HYAS.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.
Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
